USD
$0.00
(0.00%
)At Close (As of Nov 6, 2025)
$9.68M
Market Cap
-
P/E Ratio
-1.64
EPS
$15.60
52 Week High
$2.00
52 Week Low
BASIC MATERIALS
Sector
| Field | Value (USD) |
|---|---|
| Gross Profit | $1.3M |
| Total Revenue | $9.5M |
| Cost Of Revenue | $8.2M |
| Costof Goods And Services Sold | $8.2M |
| Operating Income | -$1.6M |
| Selling General And Administrative | $2M |
| Research And Development | $48K |
| Operating Expenses | $2.9M |
| Investment Income Net | - |
| Net Interest Income | $126K |
| Interest Income | $148K |
| Interest Expense | $21K |
| Non Interest Income | - |
| Other Non Operating Income | - |
| Depreciation | - |
| Depreciation And Amortization | $153K |
| Income Before Tax | -$1.6M |
| Income Tax Expense | $3.5K |
| Interest And Debt Expense | - |
| Net Income From Continuing Operations | -$1.6M |
| Comprehensive Income Net Of Tax | - |
| Ebit | -$1.6M |
| Ebitda | -$1.4M |
| Net Income | -$1.6M |
| Field | Value (USD) |
|---|---|
| Total Assets | $10M |
| Total Current Assets | $7.4M |
| Cash And Cash Equivalents At Carrying Value | $4.4M |
| Cash And Short Term Investments | $4.4M |
| Inventory | $1.4M |
| Current Net Receivables | $1.6M |
| Total Non Current Assets | $3M |
| Property Plant Equipment | - |
| Accumulated Depreciation Amortization Ppe | - |
| Intangible Assets | - |
| Intangible Assets Excluding Goodwill | - |
| Goodwill | - |
| Investments | - |
| Long Term Investments | $1.3M |
| Short Term Investments | $2.8M |
| Other Current Assets | $84K |
| Other Non Current Assets | - |
| Total Liabilities | $2.1M |
| Total Current Liabilities | $2M |
| Current Accounts Payable | $1.5M |
| Deferred Revenue | - |
| Current Debt | - |
| Short Term Debt | $68K |
| Total Non Current Liabilities | $160K |
| Capital Lease Obligations | $211K |
| Long Term Debt | - |
| Current Long Term Debt | - |
| Long Term Debt Noncurrent | - |
| Short Long Term Debt Total | $211K |
| Other Current Liabilities | $284K |
| Other Non Current Liabilities | - |
| Total Shareholder Equity | $8.3M |
| Treasury Stock | - |
| Retained Earnings | -$3.4M |
| Common Stock | $17M |
| Common Stock Shares Outstanding | $1.8M |
| Field | Value (USD) |
|---|---|
| Operating Cashflow | -$2.2M |
| Payments For Operating Activities | - |
| Proceeds From Operating Activities | - |
| Change In Operating Liabilities | - |
| Change In Operating Assets | - |
| Depreciation Depletion And Amortization | $153K |
| Capital Expenditures | $227K |
| Change In Receivables | - |
| Change In Inventory | -$251K |
| Profit Loss | - |
| Cashflow From Investment | $418K |
| Cashflow From Financing | $145K |
| Proceeds From Repayments Of Short Term Debt | - |
| Payments For Repurchase Of Common Stock | - |
| Payments For Repurchase Of Equity | - |
| Payments For Repurchase Of Preferred Stock | - |
| Dividend Payout | $68K |
| Dividend Payout Common Stock | $68K |
| Dividend Payout Preferred Stock | - |
| Proceeds From Issuance Of Common Stock | - |
| Proceeds From Issuance Of Long Term Debt And Capital Securities Net | - |
| Proceeds From Issuance Of Preferred Stock | - |
| Proceeds From Repurchase Of Equity | - |
| Proceeds From Sale Of Treasury Stock | - |
| Change In Cash And Cash Equivalents | - |
| Change In Exchange Rate | - |
| Net Income | -$1.6M |
| Field | Value (USD) |
|---|---|
| Gross Profit | $1.3M |
| Total Revenue | $9.5M |
| Cost Of Revenue | $8.2M |
| Costof Goods And Services Sold | $8.2M |
| Operating Income | -$1.6M |
| Selling General And Administrative | $2M |
| Research And Development | $48K |
| Operating Expenses | $2.9M |
| Investment Income Net | - |
| Net Interest Income | $126K |
| Interest Income | $148K |
| Interest Expense | $21K |
| Non Interest Income | - |
| Other Non Operating Income | - |
| Depreciation | - |
| Depreciation And Amortization | $153K |
| Income Before Tax | -$1.6M |
| Income Tax Expense | $3.5K |
| Interest And Debt Expense | - |
| Net Income From Continuing Operations | -$1.6M |
| Comprehensive Income Net Of Tax | - |
| Ebit | -$1.6M |
| Ebitda | -$1.4M |
| Net Income | -$1.6M |
Sector: BASIC MATERIALS
Industry: SPECIALTY CHEMICALS
BioNexus Gene Lab Corp (BGLC) is a biotechnology firm based in Kuala Lumpur, Malaysia, dedicated to pioneering advancements in genetic research and innovative therapeutic solutions. Positioned at the forefront of the biotechnology sector, BGLC harnesses state-of-the-art gene editing and biomanufacturing methodologies to tackle critical healthcare challenges. The company boasts a promising product pipeline targeting improvements in human health and agricultural productivity, thereby capitalizing on the global surge in biotechnology demand. With a steadfast commitment to sustainability and regulatory compliance, BioNexus is poised for significant growth within the dynamic biotech landscape.